Mathias, C., Goto, Y., Gross-Ophoff-Mueller, C., Lu, S., Rodriguez-Abreu, D., Zer, A., Drachsler, M. W., Gong, M., Hurlock, J., Tyszecki, J., Cho, B. C. (2025). ARTEMIDE-Lung03: A phase 3, randomized, double-blind, multicenter, global study of rilvegostomig or pembrolizumab in combination with platinum-based chemotherapy as first-line treatment for patients with metastatic non-squamous non-small-cell lung cancer whose tumors express PD-L1.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps8653